Company: Adaptive Phage Therapeutics
Job title: Co-Founder & CEO
Greg Merril is an experienced life-science entrepreneurial executive. He has served as founding CEO for four VC-backed fast growth health-related product companies. As founding CEO of Immersion Medical (NASDQ: IMMR) he led the creation of the world’s first commercially successful virtual reality surgical training simulators resulting in a company that was one of Maryland’s fastest growth technology firms for four consecutive years. He served as invited Guest Editor for the Proceedings of the IEEE Special Issue on Virtual and Augmented Reality in Medicine and as Principal Investigator on numerous federally funded research grants and as a referee/reviewer for government-sponsored and non-profit grants related to medical informatics. Greg has been recognized as a TEDMED Innovation Scholar for his work developing and commercializing head impact sensor technology to address the issue of sports-related traumatic brain injury. During his career Greg’s product developed efforts have been recognized twice as Innovation of the Year by the Consumer Electronic Association (CEA)/ Industrial Designers Society of America (IDSA). Other awards have included the 2015 International Sports Technology Award for Best Wearable Technology, A Wall Street Journal Startup Company of the Year (2013), BusinessWeek Product Design of the Year; Popular Science “Best of What’s New” winner. Greg has been recognized by Ernst & Young as a regional Entrepreneur of the Year winner.
Ensuring Phage is a Long-Term Viable Treatment Option 11:00 am
day: Day Two